APP-FUBINACA

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
APP-FUBINACA
APP-FUBINACA.png
Systematic (IUPAC) name
N-(1-amino-3-phenyl-1-oxopropan-2-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide
Clinical data
Legal status
Identifiers
CAS Number 1185282-03-4
PubChem CID: 58124515
Chemical data
Formula C24H21FN4O2
Molecular mass 416.5 g/mol
  • O=C(N[C@H](C(N)=O)CC1=CC=CC=C1)C2=NN(CC3=CC=C(F)C=C3)C4=C2C=CC=C4
  • InChI=1S/C24H21FN4O2/c25-18-12-10-17(11-13-18)15-29-21-9-5-4-8-19(21)22(28-29)24(31)27-20(23(26)30)14-16-6-2-1-3-7-16/h1-13,20H,14-15H2,(H2,26,30)(H,27,31)/t20-/m0/s1
  • Key:TZXBEYFALIFOAG-FQEVSTJZSA-N

APP-FUBINACA is an indazole-based synthetic cannabinoid that has been sold online as a designer drug.[1] Pharmacological testing showed APP-FUBINACA to have only moderate affinity for the CB1 receptor, with a Ki of 708 nM, while its EC50 was not tested.[2]

Legality

Sweden's public health agency suggested to classify APP-FUBINACA as hazardous substance on March 24, 2015.[3]

See also

<templatestyles src="Div col/styles.css"/>

References

  1. Lua error in package.lua at line 80: module 'strict' not found.
  2. Buchler IP et al, INDAZOLE DERIVATIVES. WO 2009/106982
  3. Lua error in package.lua at line 80: module 'strict' not found.

<templatestyles src="Asbox/styles.css"></templatestyles>